HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,178,285 | +14.3% | 373,224 | -6.9% | 0.09% | +15.8% |
| Q2 2023 | $37,790,917 | -10.0% | 400,874 | -4.1% | 0.08% | -14.6% |
| Q1 2023 | $41,986,026 | +76687.8% | 417,956 | -13.0% | 0.09% | -14.4% |
| Q4 2022 | $54,678 | -99.7% | 480,473 | +90.6% | 0.10% | +153.7% |
| Q3 2022 | $15,922,000 | -44.6% | 252,022 | -33.2% | 0.04% | -38.8% |
| Q2 2022 | $28,763,000 | -31.6% | 377,006 | -15.3% | 0.07% | -15.2% |
| Q1 2022 | $42,069,000 | -2.9% | 444,898 | -2.7% | 0.08% | +6.8% |
| Q4 2021 | $43,314,000 | +0.8% | 457,098 | +0.5% | 0.07% | -2.6% |
| Q3 2021 | $42,986,000 | +20.7% | 454,798 | +0.8% | 0.08% | +26.7% |
| Q2 2021 | $35,619,000 | +1524.2% | 451,098 | +1511.2% | 0.06% | +1400.0% |
| Q1 2021 | $2,193,000 | -42.5% | 27,998 | -56.1% | 0.00% | -33.3% |
| Q4 2020 | $3,814,000 | +73.9% | 63,800 | +92.7% | 0.01% | +50.0% |
| Q3 2020 | $2,193,000 | +294.4% | 33,100 | +76.5% | 0.00% | +300.0% |
| Q1 2020 | $556,000 | -97.5% | 18,756 | -97.2% | 0.00% | -97.2% |
| Q4 2019 | $21,872,000 | +61.4% | 678,200 | +25.0% | 0.04% | +63.6% |
| Q3 2019 | $13,553,000 | +181.5% | 542,611 | +138.1% | 0.02% | +175.0% |
| Q2 2019 | $4,815,000 | – | 227,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |